J. Waitzinger, H. Lenders; G. Pabst; C. Reh; E. Ulbrich, Three explorative studies on the efficacy of the antihistamine mebhydroline (Omeril)., in Int J Clin Pharmacol Ther, vol. 33, n. 7, Lug 1995, pp. 373-83, PMID 7582391.
K. Yamamoto, K. Kinoshita; S. Murota, [Successful experiences in use of Mebhydrolin (Incidal) tablets in various dermatologic diseases]., in Hifuka Kiyo, vol. 64, n. 1, Feb 1969, pp. 39-45, PMID 4390241.
GA. Young, P. Forrest; SF. Deveridge; RB. Gates; PC. Vincent, Mebhydrolin induced agranulocytosis., in Aust N Z J Med, vol. 12, n. 2, Apr 1982, pp. 173-6, PMID 6807274.
Y. Edoute, A. Nagler; B. Brenner, [Agranulocytosis associated with mebhydrolin napadisylate (Incidal)]., in Harefuah, vol. 106, n. 5, Mar 1984, pp. 208-9, PMID 6724409.
KE. McKenna, JC. McMillan, Exacerbation of psoriasis, liver dysfunction and thrombocytopenia associated with mebhydrolin., in Clin Exp Dermatol, vol. 18, n. 2, Mar 1993, pp. 131-2, PMID 8097681.
K. Kulthanan, P. Tiprungkorn; R. Linpiyawan, Cutaneous reaction to oral antihistamine., in Clin Exp Dermatol, vol. 28, n. 2, Mar 2003, pp. 229-30, PMID 12653725.
JJ. de Gier, Driving tests with patients., in Br J Clin Pharmacol, 18 Suppl 1, 1984, pp. 103S-108S, PMID 6151846.
HM. Franks, M. Lawrie; VV. Schabinsky; GA. Starmer; RK. Teo, Interaction between ethanol and antihistamines: 3. mebhydrolin., in Med J Aust, vol. 2, n. 9, Ott 1981, pp. 477-9, PMID 6119605.
SM. Zimatkin, OV. Anichtchik, Alcohol-histamine interactions., in Alcohol Alcohol, vol. 34, n. 2, pp. 141-7, PMID 10344773.
